3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Pancreatic Cancer Resectable
1
Lymphangioleiomyomatosis
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioblastoma
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms, Male
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Arthritis, Rheumatoid
1
Anatomic Stage I Breast Cancer AJCC v8
1
Adenocarcinoma of Lung
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Hydroxychloroquine
×
Clear all
No trials found.